시장보고서
상품코드
1477945

세계의 이산화탄소(CO2) 모니터 시장 예측(-2030년)

Carbon Dioxide (CO2) Monitors Market Forecast till 2030

발행일: | 리서치사: Market Research Future | 페이지 정보: 영문 142 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

이산화탄소(CO2) 모니터 시장 규모는 예측 기간 동안 7.60%의 복합 연간 성장률(CAGR)로 성장할 것으로 예측됩니다.

지역별 인사이트력

아시아태평양은 45.8% 시장 점유율로 2022년 시장을 선도했습니다. 또한 유럽은 CO2 스크린의 장점에 대한 의식이 높아져 2위 시장 점유율을 보여줍니다. 특히 독일과 영국은 유럽에서 급속한 복합 연간 성장률(CAGR)로 발전할 것으로 예상됩니다.

이 보고서는 세계 이산화탄소(CO2) 모니터 시장을 조사했으며, 시장 정의 및 개요, 시장 성장에 미치는 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각종 구분, 지역/ 주요 국가 다른 내역, 경쟁 환경, 주요 기업 프로파일 등을 정리했습니다.

목차

제1장 주요 요약

제2장 조사 범위

제3장 조사 방법

제4장 시장 상황

  • Porter's Five Forces 분석
  • 밸류체인/서플라이체인

제5장 세계 이산화탄소(CO2) 모니터 시장 : 시장 개요

  • 성장추진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 과제

제6장 세계 이산화탄소(CO2) 모니터 시장 : 제품별

  • 벽 마운트
  • 파이프라인
    • 시장 규모의 추정,예측

제7장 세계 이산화탄소(CO2) 모니터 시장 : 유형별

  • ET CO2 모니터
  • TCP CO2 모니터
    • 시장 규모의 추정,예측

제8장 세계 이산화탄소(CO2) 모니터 시장 : 용도별

  • 병원
  • 과학연구
  • 양조장
  • 온실
  • 지하 주차장
  • 오피스 빌딩
  • 기타
    • 시장 규모의 추정,예측

제9장 세계 이산화탄소(CO2) 모니터 시장 : 지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제10장 경쟁 구도

제11장 기업 프로파일

  • CRITICARE TECHNOLOGIES, INC.
  • DRAGER MEDICAL GMBH
  • GE HEALTHCARE
  • INVIVO CORPORATION
  • MASIMO CORPORATION
  • MEDTRONIC PLC
  • MINDRAY DS USA, INC.
  • NIHON KOHDEN CORPORATION
  • NONIN MEDICAL, INC.
  • OSI SYSTEMS, INC.
  • PHILIPS HEALTHCARE
  • RADIOMETER MEDICAL APS
  • SMITHS MEDICAL
  • THAMES MEDICAL

제12장 총론

BJH 24.05.21

Market Overview

The Carbon Dioxide (CO2) Monitors Market is anticipated to register a significant CAGR of 7.60% during the review period. Carbon dioxide (CO2) is captured and utilized during the time spent carbon capture and utilization. The worldwide test of impressively diminishing ozone harming substance discharges from major fixed (modern) producers might be tended to via carbon capture and utilization. As opposed to carbon capture and storage (CCS), carbon capture and utilize neither holds back nothing in the drawn out land storage of carbon dioxide. All things being equal, CCU endeavors to keep up with the carbon impartiality of the modern cycles while changing over the captured carbon dioxide into more worth materials or products, including plastics, concrete, or biodiesel.

By utilizing different strategies, carbon capture, utilization, and storage keep CO2 from being delivered into the air. The essential driver of CO2 emanations overall is the creation of power utilizing non-renewable energy sources and flammable gas. By utilizing carbon capture, utilization, and storage, ozone harming substances can be kept out of the environment. Hence, the reception of carbon capture, utilization, and storage to limit discharges is ascending because of expanded stresses over environmental change. For example, President Joe Biden marked a leader request expressing that America would make 100 percent without carbon power by 2035 because of the ascent in carbon emanations brought about by consuming petroleum products for energy, which is a figure an unnatural weather change. Besides, legislatures from various countries are giving a few advantages to arrive at net-zero emanations to empower the reception of carbon capture, utilization, and storage. Tax reductions and government endowments that help plant proprietors are only a couple of the advantages given by open organizations. During the projected period, these elements are expected to fuel market demand for carbon capture, utilization, and storage.

Market Segmentation

The Carbon Dioxide (CO2) Monitors Market is bifurcated into Wall-mounted and Pipeline carbon dioxide (CO2) monitors, based on productsO.

Based on Type the market is divided into End-tidal carbon dioxide (EtCO2) and Transcutaneous carbon dioxide (tcpCO2) monitors. The Applications segment divides the market into Hospital use, Scientific research, Breweries, greenhouses, Underground Car parks, and Office Buildings.

Regional Insights

Asia-Pacific (APAC) region leads the market with 45.8% of the market share in 2022 because of rising instances of respiratory disappointments.

European Region's Carbon Dioxide (CO2) Screens market represents the second-biggest market share because of rising consciousness of the advantages of CO2 Screens. Further, the German Carbon Dioxide (CO2) Screens market and the UK Carbon Dioxide (CO2) Screens market is expected to develop at a quick CAGR in the European Region.

The North America Carbon Dioxide (CO2) Screens Market is expected to expand essentially during the projected time span. It is expected to expanding mindfulness about CO2 checking advantages and rising air contaminations after Coronavirus. In addition, China's Carbon Dioxide (CO2) Screens market held the biggest market offer, and Japan's Carbon Dioxide (CO2) Screens market was the quickest developing market in the Asia-Pacific region.

Major Players

Key Companies in the Carbon Dioxide (CO2) Monitors market include Drager Medical GmbH, Medtronic PLC, OSI Systems Inc., Thames Medical, Criticare Systems Inc., GE Healthcare, Invivo, Masimo, Mindray North America, Nihon Kohden Corporation, Nonin Medical Inc., Philips Healthcare, Radiometer Medical ApS, and Smiths Medical.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. SCOPE OF THE REPORT

  • 2.1. MARKET DEFINITION
  • 2.2. SCOPE OF THE STUDY
    • 2.2.1. RESEARCH OBJECTIVES
    • 2.2.2. ASSUMPTIONS & LIMITATIONS
  • 2.3. MARKET STRUCTURE

3. MARKET RESEARCH METHODOLOGY

  • 3.1. RESEARCH PROCESS
  • 3.2. SECONDARY RESEARCH
  • 3.3. PRIMARY RESEARCH
  • 3.4. FORECAST MODEL

4. MARKET LANDSCAPE

  • 4.1. PORTER'S FIVE FORCES ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRANTS
    • 4.1.2. BARGAINING POWER OF BUYERS
    • 4.1.3. THREAT OF SUBSTITUTES
    • 4.1.4. INTENSITY OF RIVALRY
    • 4.1.5. BARGAINING POWER OF SUPPLIERS
  • 4.2. VALUE CHAIN/SUPPLY CHAIN OF THE GLOBAL CARBON DIOXIDE (CO2) MONITORS MARKET

5. MARKET OVERVIEW OF THE GLOBAL CARBON DIOXIDE (CO2) MONITORS MARKET

  • 5.1. INTRODUCTION
  • 5.2. GROWTH DRIVERS
  • 5.3. MARKET RESTRAINTS
  • 5.4. MARKET OPPORTUNITIES
  • 5.5. MARKET CHALLENGES

6. GLOBAL CARBON DIOXIDE (CO2) MONITORS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. WALL-MOUNTED CARBON DIOXIDE (CO2) MONITORS
    • 6.2.1. MARKET ESTIMATES & FORECAST,-2030
    • 6.2.2. MARKET ESTIMATES & FORECAST, BY REGION,-2030
  • 6.3. PIPELINE CARBON DIOXIDE (CO2) MONITORS
    • 6.3.1. MARKET ESTIMATES & FORECAST,-2030
    • 6.3.2. MARKET ESTIMATES & FORECAST, BY REGION,-2030

7. GLOBAL CARBON DIOXIDE (CO2) MONITORS MARKET, BY TYPE

  • 7.1. END-TIDAL CARBON DIOXIDE (ETCO2) MONITORS
    • 7.1.1. MARKET ESTIMATES & FORECAST,-2030
    • 7.1.2. MARKET ESTIMATES & FORECAST, BY REGION,-2030
  • 7.2. TRANSCUTANEOUS CARBON DIOXIDE (TCPCO2) MONITORS
    • 7.2.1. MARKET ESTIMATES & FORECAST,-2030
    • 7.2.2. MARKET ESTIMATES & FORECAST, BY REGION,-2030

8. GLOBAL CARBON DIOXIDE (CO2) MONITORS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. HOSPITAL USE
    • 8.2.1. MARKET ESTIMATES & FORECAST,-2030
    • 8.2.2. MARKET ESTIMATES & FORECAST, BY REGION,-2030
  • 8.3. SCIENTIFIC RESEARCH
    • 8.3.1. MARKET ESTIMATES & FORECAST,-2030
    • 8.3.2. MARKET ESTIMATES & FORECAST, BY REGION,-2030
  • 8.4. BREWERIES
    • 8.4.1. MARKET ESTIMATES & FORECAST,-2030
    • 8.4.2. MARKET ESTIMATES & FORECAST, BY REGION,-2030
  • 8.5. GREENHOUSES
    • 8.5.1. MARKET ESTIMATES & FORECAST,-2030
    • 8.5.2. MARKET ESTIMATES & FORECAST, BY REGION,-2030
  • 8.6. UNDERGROUND CAR PARKS
    • 8.6.1. MARKET ESTIMATES & FORECAST,-2030
    • 8.6.2. MARKET ESTIMATES & FORECAST, BY REGION,-2030
  • 8.7. OFFICE BUILDINGS
    • 8.7.1. MARKET ESTIMATES & FORECAST,-2030
    • 8.7.2. MARKET ESTIMATES & FORECAST, BY REGION,-2030
  • 8.8. OTHERS
    • 8.8.1. MARKET ESTIMATES & FORECAST,-2030
    • 8.8.2. MARKET ESTIMATES & FORECAST, BY REGION,-2030

9. GLOBAL CARBON DIOXIDE (CO2) MONITORS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. MARKET ESTIMATES & FORECAST, BY COUNTRY,-2030
    • 9.2.2. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
    • 9.2.3. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
    • 9.2.4. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.2.5. US
      • 9.2.5.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.2.5.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.2.5.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.2.6. CANADA
      • 9.2.6.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.2.6.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.2.6.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.2.7. MEXICO
      • 9.2.7.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.2.7.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.2.7.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
  • 9.3. EUROPE
    • 9.3.1. MARKET ESTIMATES & FORECAST, BY COUNTRY,-2030
    • 9.3.2. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
    • 9.3.3. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
    • 9.3.4. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.3.5. UK
      • 9.3.5.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.3.5.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.3.5.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.3.6. GERMANY
      • 9.3.6.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.3.6.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.3.6.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.3.7. FRANCE
      • 9.3.7.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.3.7.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.3.7.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.3.8. ITALY
      • 9.3.8.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.3.8.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.3.8.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.3.9. REST OF EUROPE
      • 9.3.9.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.3.9.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.3.9.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
  • 9.4. ASIA-PACIFIC
    • 9.4.1. MARKET ESTIMATES & FORECAST, BY COUNTRY,-2030
    • 9.4.2. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
    • 9.4.3. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
    • 9.4.4. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.4.5. CHINA
      • 9.4.5.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.4.5.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.4.5.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.4.6. JAPAN
      • 9.4.6.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.4.6.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.4.6.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.4.7. INDIA
      • 9.4.7.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.4.7.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.4.7.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.4.8. REST OF ASIA-PACIFIC
      • 9.4.8.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.4.8.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.4.8.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
  • 9.5. REST OF THE WORLD
    • 9.5.1. MARKET ESTIMATES & FORECAST, BY, COUNTRY,-2030
    • 9.5.2. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
    • 9.5.3. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
    • 9.5.4. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.5.5. THE MIDDLE EAST & AFRICA
      • 9.5.5.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.5.5.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.5.5.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030
    • 9.5.6. SOUTH AMERICA
      • 9.5.6.1. MARKET ESTIMATES & FORECAST, BY PRODUCT,-2030
      • 9.5.6.2. MARKET ESTIMATES & FORECAST, BY TYPE,-2030
      • 9.5.6.3. MARKET ESTIMATES & FORECAST, BY APPLICATION,-2030

10. COMPETITIVE LANDSCAPE

11. COMPANY PROFILES

  • 11.1. CRITICARE TECHNOLOGIES, INC.
    • 11.1.1. COMPANY OVERVIEW
    • 11.1.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.1.3. FINANCIAL UPDATES
    • 11.1.4. KEY DEVELOPMENTS
    • 11.1.5. SWOT ANALYSIS
    • 11.1.6. KEY STRATEGIES
  • 11.2. DRAGER MEDICAL GMBH
    • 11.2.1. COMPANY OVERVIEW
    • 11.2.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.2.3. FINANCIAL UPDATES
    • 11.2.4. KEY DEVELOPMENTS
    • 11.2.5. SWOT ANALYSIS
    • 11.2.6. KEY STRATEGIES
  • 11.3. GE HEALTHCARE
    • 11.3.1. COMPANY OVERVIEW
    • 11.3.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.3.3. FINANCIAL UPDATES
    • 11.3.4. KEY DEVELOPMENTS
    • 11.3.5. SWOT ANALYSIS
    • 11.3.6. KEY STRATEGIES
  • 11.4. INVIVO CORPORATION
    • 11.4.1. COMPANY OVERVIEW
    • 11.4.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.4.3. FINANCIAL UPDATES
    • 11.4.4. KEY DEVELOPMENTS
    • 11.4.5. SWOT ANALYSIS
    • 11.4.6. KEY STRATEGIES
  • 11.5. MASIMO CORPORATION
    • 11.5.1. COMPANY OVERVIEW
    • 11.5.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.5.3. FINANCIAL UPDATES
    • 11.5.4. KEY DEVELOPMENTS
    • 11.5.5. SWOT ANALYSIS
    • 11.5.6. KEY STRATEGIES
  • 11.6. MEDTRONIC PLC
    • 11.6.1. COMPANY OVERVIEW
    • 11.6.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.6.3. FINANCIAL UPDATES
    • 11.6.4. KEY DEVELOPMENTS
    • 11.6.5. SWOT ANALYSIS
    • 11.6.6. KEY STRATEGIES
  • 11.7. MINDRAY DS USA, INC.
    • 11.7.1. COMPANY OVERVIEW
    • 11.7.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.7.3. FINANCIAL UPDATES
    • 11.7.4. KEY DEVELOPMENTS
    • 11.7.5. SWOT ANALYSIS
    • 11.7.6. KEY STRATEGIES
  • 11.8. NIHON KOHDEN CORPORATION
    • 11.8.1. COMPANY OVERVIEW
    • 11.8.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.8.3. FINANCIAL UPDATES
    • 11.8.4. KEY DEVELOPMENTS
    • 11.8.5. SWOT ANALYSIS
    • 11.8.6. KEY STRATEGIES
  • 11.9. NONIN MEDICAL, INC.
    • 11.9.1. COMPANY OVERVIEW
    • 11.9.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.9.3. FINANCIAL UPDATES
    • 11.9.4. KEY DEVELOPMENTS
    • 11.9.5. SWOT ANALYSIS
    • 11.9.6. KEY STRATEGIES
  • 11.10. OSI SYSTEMS, INC.
    • 11.10.1. COMPANY OVERVIEW
    • 11.10.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.10.3. FINANCIAL UPDATES
    • 11.10.4. KEY DEVELOPMENTS
    • 11.10.5. SWOT ANALYSIS
    • 11.10.6. KEY STRATEGIES
  • 11.11. PHILIPS HEALTHCARE
    • 11.11.1. COMPANY OVERVIEW
    • 11.11.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.11.3. FINANCIAL UPDATES
    • 11.11.4. KEY DEVELOPMENTS
    • 11.11.5. SWOT ANALYSIS
    • 11.11.6. KEY STRATEGIES
  • 11.12. RADIOMETER MEDICAL APS
    • 11.12.1. COMPANY OVERVIEW
    • 11.12.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.12.3. FINANCIAL UPDATES
    • 11.12.4. KEY DEVELOPMENTS
    • 11.12.5. SWOT ANALYSIS
    • 11.12.6. KEY STRATEGIES
  • 11.13. SMITHS MEDICAL
    • 11.13.1. COMPANY OVERVIEW
    • 11.13.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.13.3. FINANCIAL UPDATES
    • 11.13.4. KEY DEVELOPMENTS
    • 11.13.5. SWOT ANALYSIS
    • 11.13.6. KEY STRATEGIES
  • 11.14. THAMES MEDICAL
    • 11.14.1. COMPANY OVERVIEW
    • 11.14.2. PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.14.3. FINANCIAL UPDATES
    • 11.14.4. KEY DEVELOPMENTS
    • 11.14.5. SWOT ANALYSIS
    • 11.14.6. KEY STRATEGIES

12. CONCLUSION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제